Stock Market News 2 January 2026

Klaviyo stock sinks in first 2026 session as software selloff bites KVYO

NEW YORK, Jan 2, 2026, 14:22 ET — Regular session Klaviyo, Inc. shares fell more than 8% on Friday afternoon, extending a pullback in software stocks in the first regular trading session of 2026. The stock was down 8.4% at $29.75 after moving between $32.46 and $29.64 on the day, according to market data. The move matters because investors are re-pricing rate-sensitive growth names at the start of the year, when positioning often resets and liquidity can thin out. For smaller software companies, that can amplify day-to-day swings. Software broadly lagged. The iShares Expanded Tech-Software Sector ETF fell about 3.1%,

2 January 2026

NASDAQ:KVYO·Stock Market·Technology

Uber stock rises as UK VAT ‘taxi tax’ takes effect; what investors watch next

NEW YORK, Jan 2, 2026, 14:30 ET — Regular session Uber Technologies (UBER.N) shares were up 0.9% at $82.48 on Friday afternoon. The move came as investors tracked a UK tax change affecting ride-hailing economics and Uber’s contract rewrite for drivers outside London. The Guardian The timing matters because the UK’s value-added tax (VAT) — a sales tax — can quickly change what riders pay and what drivers earn. Those two levers often decide whether ride-hailing platforms can grow volumes without giving up margins. The Guardian Britain said on Friday that private-hire vehicle operators in London can no longer use

2 January 2026

NASDAQ:UBER·Stock Market·UK Economy

Corcept Therapeutics (CORT) stock rebounds today after FDA setback — here’s what investors are watching next

NEW YORK, January 2, 2026, 2:30 PM ET — Regular session Corcept Therapeutics Incorporated shares were up 5.7% at $36.77 on Friday afternoon, after a sharp selloff earlier in the week tied to a U.S. regulatory setback for its experimental drug relacorilant. The bounce matters because the FDA’s decision hit what investors had seen as a key growth driver beyond Corcept’s marketed therapy, and it reset expectations for how quickly relacorilant can reach patients in the company’s lead endocrine indication. A complete response letter is the FDA’s notice that a drug application cannot be approved as filed. For investors, it

2 January 2026

NASDAQ:CORT·Pharmaceuticals·Stock Market

Exzeo (XZO) stock drops nearly 8% in New Year trading — what investors are watching next

NEW YORK, Jan 2, 2026, 14:20 ET — Regular session Shares of Exzeo Group Inc slid on Friday, down $1.89, or about 7.8%, at $22.36 in afternoon trading. The NYSE-listed stock traded between $22.25 and $24.18, with about 164,000 shares changing hands. The move stood out on a relatively calm tape, as U.S. equities wobbled into the first full session of 2026 and investors reset positioning after year-end. Thin liquidity in newer listings can amplify swings even when the broader market is steady. Exzeo, founded in 2012, provides software and analytics tools that help property-and-casualty insurers streamline tasks such as

2 January 2026

NYSE:XZO·Stock Market

Liquidia stock drops 8% today as put-option hedging spikes — what’s next for LQDANEW YORK, Jan 2, 2026, 14:24 ET — Regular session

Liquidia Corp shares slid about 8% in afternoon trade on Friday, giving back earlier gains and underperforming the broader biotech group. The stock was down $2.79 at $31.70, after trading between $30.76 and $34.97. Volume topped 1.88 million shares. The move matters because Liquidia has become a high-volatility bet on sales of Yutrepia, its inhaled treprostinil therapy for pulmonary hypertension. On its Nov. 3 earnings call, the company said third-quarter net product sales were $51.7 million, and chief operating officer and CFO Michael Kaseta told investors, “We expect this positive trend to extend into 2026.” Investing Liquidia entered 2026 after

2 January 2026

NASDAQ:INSM·NASDAQ:LQDA·NASDAQ:UTHR·Stock Market

Verizon stock today: VZ slips as fresh SEC filings hit tape; rates and earnings loom

NEW YORK, Jan 2, 2026, 2:26 PM ET — Regular session Verizon Communications Inc shares edged lower on Friday after a cluster of U.S. regulatory filings detailed year-end “phantom stock” transactions by senior executives. The stock was down 0.1% at $40.67 as of 2:26 p.m. ET, after trading between $40.32 and $40.90. The disclosures land as investors reset positions at the start of 2026, with interest-rate expectations back in focus. Verizon is widely held for its steady cash flows, making it one of the telecom names that can move with rates as investors compare dividend stocks with bond yields. Treasury

2 January 2026

Earnings Reports·NASDAQ:VZ·Stock Market

Applied Digital stock jumps 15% today as ChronoScale spinoff plan and Jan. 7 earnings come into focus (APLD)

NEW YORK, Jan 2, 2026, 14:15 ET — Regular session Applied Digital Corp shares jumped 15.4% on Friday, as the data-center operator extended a sharp rally into the first full trading week of 2026. The stock was up $3.77 at $28.29, after trading between $24.65 and $28.36. The move comes days after Applied Digital said it plans to spin out its cloud computing business and combine it with EKSO Bionics Holdings to form a new AI-focused platform called ChronoScale. Applied Digital, based in Dallas, describes itself as a builder and operator of high-performance data centers and colocation facilities for AI,

2 January 2026

Earnings Reports·NASDAQ:APLD·NASDAQ:EKSO·Stock Market

Wave Life Sciences stock tumbles 8.5% in first 2026 session as traders refocus on next WVE-007 readout

NEW YORK, January 2, 2026, 14:13 ET — Regular session Wave Life Sciences Ltd shares slid on Friday, giving back part of last month’s obesity-driven run as the biotech sector wobbled in the first U.S. session of 2026. The stock was down about 8.5% at $15.55 as of 2:13 p.m. ET. The retreat matters because Wave has become a high-volatility obesity “story stock,” with investors trying to price the upside of an early-stage program against the risks that come with thin clinical data and heavy funding needs. The shares more than doubled on December 8 after the company posted interim

2 January 2026

Biotechnology·NASDAQ:WVE·Stock Market

Citigroup stock rises as Wall Street opens 2026; jobs data and Citi earnings are next

NEW YORK, Jan 2, 2026, 2:13 PM ET — Regular session Citigroup (C) shares climbed about 1.4% to $118.30 on Friday afternoon, outpacing a choppy broader market on the first trading day of 2026. The move matters because banks often swing with interest-rate expectations, which are being reset early in the new year. Treasury yields inched higher, and investors are looking to next week’s U.S. labor-market data for clues on how quickly the Federal Reserve might cut rates again. Reuters Citi has its own catalyst close ahead. The bank is due to release fourth-quarter results at about 8 a.m. ET

2 January 2026

Earnings Reports·NYSE:C·Stock Market

SMCI stock jumps today after Supermicro unveils liquid‑cooled SuperBlade server with Intel Xeon 6900

NEW YORK, January 2, 2026, 2:07 PM ET — Regular session Shares of Super Micro Computer, Inc. climbed about 5.5% on Friday after the server maker disclosed a new high-density, direct liquid‑cooled system aimed at artificial intelligence and high‑performance computing workloads. Supermicro The news matters because data‑center operators are trying to pack more compute into existing footprints while running into power and heat constraints, especially in AI training and inference clusters. Direct liquid cooling—using coolant routed through cold plates attached to hot components—has gained attention as racks get denser and air cooling becomes harder to scale efficiently. SMCI was up

2 January 2026

Data Centers·NASDAQ:SMCI·Stock Market

Paymentus stock tumbles nearly 10% as fintech slides; oversold RSI flashes for PAY

NEW YORK, Jan 2, 2026, 2:07 PM ET — Regular session Paymentus Holdings, Inc. shares were down 9.7% at $28.53 in afternoon trading on Friday, after touching a session low of $28.53. The stock opened at $31.43, hit an intraday high of $31.63 and has traded about 703,000 shares, compared with a prior close of $31.59. The slide matters because Paymentus, a bill-payment software provider, has traded like a sentiment gauge for investors’ appetite for growth-oriented payments names. A near-double-digit move in a single session can force portfolio managers and short-term traders to reassess positioning quickly. The drop also lands

2 January 2026

Fintech·NASDAQ:PAY·Stock Market

AbbVie stock edges up today as Linzess partner Ironwood cuts list price, lifts 2026 outlook

NEW YORK, Jan 2, 2026, 14:08 ET — Regular session AbbVie shares ticked higher on Friday after Ironwood Pharmaceuticals, its partner on constipation drug Linzess, raised its 2026 outlook and said it lowered the medicine’s list price at the start of the year. The update matters because Linzess is co-developed and co-commercialized with AbbVie in the U.S., and changes in pricing can shift how much revenue is left after rebates and discounts. It also lands as investors reopen the books for 2026 with drug pricing back on the agenda and macro data next week expected to reset interest-rate bets, a

2 January 2026

NASDAQ:IRWD·NYSE:ABBV·Pharmaceuticals·Stock Market

Why IREN stock is up today: bitcoin bounce sparks an ~12% jump

NEW YORK, January 2, 2026, 13:55 ET — Regular session IREN Limited (NASDAQ: IREN) shares rose about 12% on Friday to $42.25, tracking a rebound in bitcoin and a broad rally across U.S.-listed crypto miners. Bitcoin was up about 1.8% near $89,700 after topping $90,000 earlier, while peers Marathon Digital, Riot Platforms and CleanSpark were up roughly 9% to 13%; IREN traded between $38.10 and $42.40 on the day as volume reached about 19.2 million shares. The move matters because IREN has become a high-beta proxy for two volatile themes at once: bitcoin mining and the rush to build data

2 January 2026

Bitcoin·Cryptocurrency·NASDAQ:IREN·Stock Market

Pfizer stock rises today as 2026 drug price hikes grab headlines again — what PFE investors are watching

NEW YORK, January 2, 2026, 13:56 ET — Regular session Pfizer Inc shares rose 0.8% to $25.09 on Friday, as investors digested renewed attention on U.S. drug pricing and early-year list-price changes. The timing matters. January is when drugmakers typically reset U.S. prices, and the moves can quickly become a political and regulatory flashpoint — especially as the Trump administration keeps pressing for lower costs. For Pfizer, pricing headlines also land as the company tries to stabilize revenue after pandemic-era demand faded. Investors are sensitive to anything that could trigger tougher scrutiny or force steeper discounts. List price is the

2 January 2026

NYSE:PFE·Pharmaceuticals·Stock Market

Wells Fargo stock rises today as traders eye jobs report, big-bank earnings kickoff

NEW YORK, January 2, 2026, 13:55 ET — Regular session Wells Fargo & Company (WFC) shares rose 1.2% to $94.35 in early afternoon trading on Friday, after swinging between $92.81 and $94.43. The move comes as investors head into the first full trading week of 2026 with the U.S. jobs report due Jan. 9 and consumer price data on Jan. 13, the same day JPMorgan is set to open the big-bank earnings season. The Fed cut rates at each of its last three meetings of 2025, and fed funds futures — derivatives that track where traders see policy rates —

2 January 2026

Earnings Reports·NYSE:WFC·Stock Market

Camtek stock jumps 8% today as chip-equipment rally lifts CAMT; traders eye Fed, jobs data

NEW YORK, Jan 2, 2026, 1:50 PM ET — Regular session Camtek Ltd shares rose 8.1% to $115 in afternoon trading on Friday, after swinging between $108.90 and $116. The stock opened at $110.55 and had traded about 145,500 shares. The move puts the semiconductor inspection-equipment maker back in focus as investors start 2026 hunting for strength inside technology. Chip-related names have been prone to sharp, fast moves as money rotates between risk-on and risk-off trades. Chip stocks led gains on Wall Street even as the main indexes traded muted; the Philadelphia SE Semiconductor index — a basket of U.S.-listed

2 January 2026

Federal Reserve·NASDAQ:CAMT·Stock Market

Vertiv stock surges 8% on Barclays upgrade — what Wall Street is watching next

NEW YORK, January 2, 2026, 13:40 ET — Regular session Vertiv Holdings Co shares were up 8.2% at $175.33 in afternoon trading on Friday after Barclays upgraded the data-center power and cooling supplier and raised its price target to $200. Barclays analyst Julian Mitchell said the stock had “substantial upside potential” to consensus earnings estimates in 2026 and 2027. TipRanks The call matters because investors have been treating data-center infrastructure as a front-line trade on artificial intelligence spending, and small shifts in expected demand can swing valuations. Vertiv sells the power and thermal gear that keeps high-density servers running. Barclays’

2 January 2026

NYSE:VRT·Stock Market

Silver price stock today: SLV ticks higher as bullion firms, miners lag

NEW YORK, January 2, 2026, 13:42 ET — Regular session Shares of the iShares Silver Trust (SLV) rose 0.8% to $64.96 by 1:31 p.m. ET, while the Sprott Physical Silver Trust (PSLV) gained 1.0% to $23.88. The moves put “silver price today” back in focus as investors reopened positions after a volatile finish to 2025 and an outsized run in precious metals. It matters because silver sits at the intersection of safe-haven demand and industrial consumption. That mix can amplify swings when markets are repricing U.S. interest-rate expectations. Physically backed ETFs such as SLV and PSLV tend to track bullion

2 January 2026

NYSE:AG·NYSE:HL·NYSE:PAAS·NYSE:PSLV·NYSE:SLV·Precious Metals·Silver Price·Stock Market

NuScale Power (SMR) stock jumps 13% today as nuclear shares rally — what’s driving the move

NEW YORK, Jan 2, 2026, 1:04 PM ET — Regular session Shares of NuScale Power Corp (NYSE:SMR) climbed on Friday, lifting the nuclear technology stock early in the first session of 2026. The shares were up 13.2% at $16.05, after touching $16.07, with about 17.6 million shares traded. The move matters because NuScale sits in a pocket of the market where flows can dominate fundamentals for long stretches. Investors treat small modular reactor developers as a long-duration bet on future electricity demand, making the stocks sensitive to shifts in risk appetite. Friday’s jump also stood out against a mixed tape,

2 January 2026

NYSE:CCJ·NYSE:SMR·Stock Market

Natural gas price today: Futures slip as Cheniere stock climbs on record U.S. LNG exports

NEW YORK, Jan 2, 2026, 13:44 ET — Regular session U.S. natural gas futures edged lower on Friday, while shares of liquefied natural gas (LNG) exporters and pipeline operators traded higher in a mixed energy tape. Barchart The moves matter now because winter heating demand can swing quickly with temperature forecasts, and U.S. LNG exports have become a bigger, steadier source of demand for domestic gas. Barchart They also matter for stocks because gas-focused producers are closely tied to price moves, while LNG exporters and pipeline operators tend to benefit from volumes moving through their plants and pipes. The February

2 January 2026

Energy Markets·Natural Gas·NYSE:LNG·Stock Market

Stock Market News 2 January 2026

Klaviyo stock sinks in first 2026 session as software selloff bites KVYO

Uber stock rises as UK VAT ‘taxi tax’ takes effect; what investors watch next

Corcept Therapeutics (CORT) stock rebounds today after FDA setback — here’s what investors are watching next

Exzeo (XZO) stock drops nearly 8% in New Year trading — what investors are watching next

Liquidia stock drops 8% today as put-option hedging spikes — what’s next for LQDANEW YORK, Jan 2, 2026, 14:24 ET — Regular session

Verizon stock today: VZ slips as fresh SEC filings hit tape; rates and earnings loom

Applied Digital stock jumps 15% today as ChronoScale spinoff plan and Jan. 7 earnings come into focus (APLD)

Wave Life Sciences stock tumbles 8.5% in first 2026 session as traders refocus on next WVE-007 readout

Citigroup stock rises as Wall Street opens 2026; jobs data and Citi earnings are next

SMCI stock jumps today after Supermicro unveils liquid‑cooled SuperBlade server with Intel Xeon 6900

Paymentus stock tumbles nearly 10% as fintech slides; oversold RSI flashes for PAY

AbbVie stock edges up today as Linzess partner Ironwood cuts list price, lifts 2026 outlook

Why IREN stock is up today: bitcoin bounce sparks an ~12% jump

Pfizer stock rises today as 2026 drug price hikes grab headlines again — what PFE investors are watching

Wells Fargo stock rises today as traders eye jobs report, big-bank earnings kickoff

Camtek stock jumps 8% today as chip-equipment rally lifts CAMT; traders eye Fed, jobs data

Vertiv stock surges 8% on Barclays upgrade — what Wall Street is watching next

Silver price stock today: SLV ticks higher as bullion firms, miners lag

NuScale Power (SMR) stock jumps 13% today as nuclear shares rally — what’s driving the move

Natural gas price today: Futures slip as Cheniere stock climbs on record U.S. LNG exports

Stock Market Today

AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

SK hynix stock price slips into Monday after S&P upgrade, tech selloff

Bank of America stock jumps 3% into the weekend — what to watch before Monday’s trade

Oracle stock rebounds from eight-day skid as $20 billion share-sale plan looms